MDA’s partnership in research includes collaborative research grants with the ALS Network, Cure ADSSL1, Coalition to Cure ...

J&J gains EU approval for Imaavy, the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its ...

Protego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new ...

Mast cell activation syndrome is a condition that causes mast cells to release an inappropriate amount of chemicals into your body. This causes allergy symptoms and a wide range of other symptoms.

Sara Ghanem and Samar Farag remember the exact moment they became friends, and their lives changed forever. With the constant sound of machines beeping in the background and the hustle and bustle of ...

South Korea: A new clinical scoring system, known as the Scoring System for Cancer Risk in Idiopathic Inflammatory Myositis ...

Samagra Shiksha Abhiyan offers home-based learning for students with severe disabilities, yet problems in access, awareness, ...

DelveInsight's Mitochondrial Myopathies Market Insights report includes a comprehensive understanding of current treatment practices, mitochondrial myopathies emerging drugs, market share of ...

An overview of vitamin D metabolism, deficiency and the key preventive and management strategies undertaken in primary care.

Detailed price information for Zai Lab Ltd ADR (ZLAB-Q) from The Globe and Mail including charting and trades.